Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 2,544

Dr. Aubrey de Grey, is a world-famous author and biomedical gerontologist and Chief Science Officer of the SENS Research Foundation. His acclaimed lectures worldwide, include Israel and Russia and Ted Talks.

Bill Faloon, is the highly respected author of numerous articles and books, most recently: Pharmocracy II: How Corrupt Deals and Misguided Medical Regulations Are Bankrupting America—And What to Do about It.

He is co-founder of Life Extension. — An organization in the forefront of research to induce systemic rejuvenation and age reversal.

Produced and hosted on 01-25-2018 by Richard Peritz for broadcast on ABC TV-25 and networks nationwide. Show 1050.

Read more

Summary: A new report provides good news for warding off stroke and hardening of the arteries, two diseases of aging. Combining blood-pressure-lowering drugs with cholesterol-lowering medications reduced first-time strokes by 44%, according to a report by the AHA/ASA. [This article first appeared on the website LongevityFacts.com. Author: Brady Hartman. ]

Stroke is the fifth leading cause of death in the US and a disease of aging that grows more prevalent with each birthday.

Now, a report says a new drug regimen promises to cut that risk nearly in half.

Read more

A simple technique to measure the amount of amyloid beta in the brain could improve diagnosis and drug trials for Alzheimer’s disease, according to the results of new research.

A simple blood test

Japanese researchers led by Dr. Katsuhiko Yanagisawa have published a new study suggesting that a screening test could help to boost the success rate of Alzheimer’s drug research. The research team has shown that a simple blood test can accurately measure the amount of amyloid beta, a protein that appears in the early stages of Alzheimer’s disease.

Read more

SciShow created a well-produced video on why whales don’t get cancer. The video shows how researchers have discovered extra cancer-fighting genes in elephants and whales and plan to apply these lessons to fighting cancer in humans.

(video) Researchers are investigating why blue whales don’t get cancer and plan to apply this lessons to fighting cancer in humans.

Read more

Tickling the brain with low-intensity electrical stimulation in a specific area can improve verbal short-term memory. Mayo Clinic researchers report their findings in Brain.

The researchers found word recall was enhanced with stimulation of the brain’s lateral temporal cortex, the regions on the sides of the head by the temples and ears. Patients recalled more words from a previously viewed list when low-amplitude was delivered to the brain. One patient reported that it was easier to picture the words in his mind for remembering.

“The most exciting finding of this research is that our for language information can be improved by directly stimulating this underexplored brain area,” says Michal Kucewicz, Ph.D., a Mayo Clinic researcher in the Department of Neurology and co-first author. Dr. Kucewicz compares the stimulation to “tickling” the brain.

Read more

I suspect this will be the hands for ATLAS. being field tested by human volunteers to see what it needs to do for average use. And, then blow that away within a few years.

Johnny Matheny is the first person to live with an advanced mind-controlled robotic arm. Last December, researchers from Johns Hopkins Applied Physics Lab delivered the arm to Matheny at his home in Port Richey, Florida. Aside from the occasional demo, this is the first time the Modular Prosthetic Limb (MPL) has spent significant time out of the lab.

Johns Hopkins has received more than $120 million from the US Defense Department to help pay for the arm’s development over the past 10 years.

Matheny, who lost his arm to cancer in 2005, is the first person to live with the MPL, but there are plans to have others try it out this year. There are a few things Matheny is not allowed to do with the arm, like getting it wet or drive while wearing it. But beyond that, the goal is to push the robotic prosthetic to its limits.

Read more

Last year, we talked about a new cancer “vaccine” currently in clinical trials in an article here, and now a second cancer vaccine is capturing media interest due to impressive results in the lab. The new therapy is now in human clinical trials for lymphoma patients.

Researchers at Stanford Medicine have found that injecting two immune system stimulating agents directly into a solid tumor can eradicate the tumor completely. The treatment is also able to destroy distant metastases that have not been directly treated themselves.

Read more